101. Quality control of cytotoxic infusions disturbed by a change of infusion bag: A case report. Issue 2 (April 2019) Authors: Le Quinio, Pierre; Beiler, Benoît; Lider, Pauline; Demoré, Béatrice; Vigneron, Jean Journal: European journal of oncology pharmacy Issue: Volume 2:Issue 2(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
102. Receptor tyrosine kinases. (2020) Editors: Fisher, Paul B; (Professor of Biotechnology), Kumar, Rakesh Record Type: Book Extent: 1 online resource View Content: Available online (eLD content is only available in our Reading Rooms) ↗
103. Recurrence rate in patients with stage IV breast cancer: a retrospective cohort study. Issue 2 (6th April 2023) Authors: Grobler, Leanda; Orchard, Ané; Moodley, Shun D.; Pypers, Ion; Khan, Razeeya Journal: European journal of oncology pharmacy Issue: Volume 6:Issue 2(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
104. Reduction of patient waiting time by the preparation and administration of trastuzumab and pertuzumab in a single infusion bag: a 1-year review, retrospective, single institution experience in a French cancer center. Issue 2 (17th April 2021) Authors: Deppenweiler, Marine; Teytaud, Manon; Stein, Philippe; Donamaria, Catherine; Lortal, Barbara Journal: European journal of oncology pharmacy Issue: Volume 4:Issue 2 (2021) Page Start: e029 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
105. Resistance to anti-cancer therapeutics targeting receptor tyrosine kinases and downstream pathways. (2018) Editors: Yarden, Y (Yosef); Elkabets, Moshe Record Type: Book Extent: 1 online resource View Content: Available online (eLD content is only available in our Reading Rooms) ↗
106. Resistance to targeted ABC transporters in cancer. ([2015]) Editors: Efferth, Thomas, 1960- Record Type: Book Extent: 1 online resource (x, 300 pages), illustrations (some color) View Content: Available online (eLD content is only available in our Reading Rooms) ↗
107. Rethinking platinum anticancer drug design : towards targeted and immuno-chemotherapeutic approaches /: towards targeted and immuno-chemotherapeutic approaches. ([2018]) Authors: Wong, Daniel Yuan Qiang Record Type: Book Extent: 1 online resource, illustrations (some color) View Content: Available online (eLD content is only available in our Reading Rooms) ↗
108. Role of nutraceuticals in cancer chemosensitization. (2017) Editors: Bharti, Alok Chandra; Aggarwal, Bharat B, 1950- Record Type: Book Extent: 1 online resource View Content: Available online (eLD content is only available in our Reading Rooms) ↗
109. Safety of pertuzumab and trastuzumab administered in a single infusion bag in breast cancer: A retrospective, single-institution experience. Issue 3 (14th July 2020) Authors: De Coucy, Antoine; Ollivier, Julien; Malifarge, Laura; Deppenweiler, Marine; Donamaria, Catherine; Lortal, Barbara Journal: European journal of oncology pharmacy Issue: Volume 3:Issue 3(2020) Page Start: e26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
110. SCIENTIFIC PROGRAMME. (October 2018) Authors: N/A, Journal: European journal of oncology pharmacy Issue: Volume1:Supplement 3(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗